{"sentence": "Co-administration with efavirenz or <e1> fluconazole </e1> had a modest effect on the pharmacokinetics of <e2> azithromycin </e2> .", "relation": "1", "e1": "fluconazole", "e2": "azithromycin", "evs": ""}
{"sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, <e1> nortriptyline </e1> , olanzapine, oral contraceptives(3), <e2> oxcarbazepine </e2> , Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.", "relation": "0", "e1": "nortriptyline", "e2": "oxcarbazepine", "evs": ""}
{"sentence": "Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, <e1> indomethacin </e1> ), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with <e2> PROLEUKIN </e2> may increase toxicity in these organ systems.", "relation": "1", "e1": "indomethacin", "e2": "PROLEUKIN", "evs": ""}
{"sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, <e1> delavirdine </e1> , desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , <e2> ziprasidone </e2> , and zonisamide.", "relation": "0", "e1": "delavirdine", "e2": "ziprasidone", "evs": ""}
{"sentence": "Therefore, concurrent use of <e1> Trileptal </e1> with <e2> hormonal contraceptives </e2> may render these contraceptives less effective.", "relation": "1", "e1": "Trileptal", "e2": "hormonal contraceptives", "evs": ""}
{"sentence": "The steady state plasma concentrations of <e1> imipramine </e1> and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of <e2> alprazolam </e2> tablets in doses up to 4 mg/day.", "relation": "1", "e1": "imipramine", "e2": "alprazolam", "evs": ""}
{"sentence": "The following are examples of drugs known to inhibit the metabolism of other related <e1> benzodiazepines </e1> , presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, diltiazem, <e2> isoniazide </e2> , and some macrolide antibiotics.", "relation": "1", "e1": "benzodiazepines", "e2": "isoniazide", "evs": ""}
{"sentence": "acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/ <e1> acetaminophen </e1> , phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and <e2> valproic acid </e2> /phenobarbital.", "relation": "0", "e1": "acetaminophen", "e2": "valproic acid", "evs": ""}
{"sentence": "The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as <e1> loop diuretics </e1> ) can be acutely worsened by <e2> beta-agonists </e2> , especially when the recommended dose of the beta-agonist is exceeded.", "relation": "1", "e1": "loop diuretics", "e2": "beta-agonists", "evs": ""}
{"sentence": "<e1> Glyburide </e1> : The concomitant administration of <e2> ciprofloxacin </e2> with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia.", "relation": "0", "e1": "Glyburide", "e2": "ciprofloxacin", "evs": ""}
{"sentence": "- Anabolic steroids (nandrolone [e.g., <e1> Anabolin </e1> ], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., <e2> Winstrol </e2> ]) or", "relation": "0", "e1": "Anabolin", "e2": "Winstrol", "evs": ""}
{"sentence": "<e1> NSAIDs </e1> may decrease the hemodynamic effects of <e2> hydralazine </e2> ;", "relation": "1", "e1": "NSAIDs", "e2": "hydralazine", "evs": ""}
{"sentence": "<e1> WelChol </e1> decreased the Cmax and AUC of sustained-release verapamil ( <e2> Calan SR </e2> ) by approximately 31% and 11%, respectively.", "relation": "1", "e1": "WelChol", "e2": "Calan SR", "evs": ""}
{"sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, <e1> buspirone </e1> , citalopram, clobazam, clonazepam, <e2> clozapine </e2> , cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.", "relation": "0", "e1": "buspirone", "e2": "clozapine", "evs": ""}
{"sentence": "Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: <e1> ergotamine </e1> , cyclosporine, <e2> amiodarone </e2> , nicardipine, and nifedipine.", "relation": "0", "e1": "ergotamine", "e2": "amiodarone", "evs": ""}
{"sentence": "While all the selective serotonin reuptake inhibitors ( <e1> SSRIs </e1> ), e.g., fluoxetine, sertraline, paroxetine, and <e2> fluvoxamine </e2> , inhibit P450 2D6, they may vary in the extent of inhibition.", "relation": "0", "e1": "SSRIs", "e2": "fluvoxamine", "evs": ""}
{"sentence": "Concomitant Crohn s disease medications were <e1> antibiotics </e1> , <e2> antivirals </e2> , corticosteroids, 6-MP/AZA and aminosalicylates.", "relation": "0", "e1": "antibiotics", "e2": "antivirals", "evs": ""}
{"sentence": "Hypotension, AV conduction disturbances, and left ventricular failure have been reported in some patients receiving <e1> beta-adrenergic blocking agents </e1> when an oral <e2> calcium antagonist </e2> was added to the treatment regimen.", "relation": "1", "e1": "beta-adrenergic blocking agents", "e2": "calcium antagonist", "evs": ""}
{"sentence": "Probenecid : <e1> Probenecid </e1> is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, <e2> benzodiazepines </e2> , bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).", "relation": "1", "e1": "Probenecid", "e2": "benzodiazepines", "evs": ""}
{"sentence": "Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, <e1> alprazolam </e1> , <e2> amitriptyline </e2> , bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.", "relation": "0", "e1": "alprazolam", "e2": "amitriptyline", "evs": ""}
{"sentence": "Concurrent administration of <e1> oxyphenbutazone </e1> and <e2> androgens </e2> may result in elevated serum levels of oxyphenbutazone.", "relation": "1", "e1": "oxyphenbutazone", "e2": "androgens", "evs": ""}
{"sentence": "Drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues, chloramphenicol, cisplatin, dapsone, disulfiram, ethionamide, glutethimide, gold, hydralazine, iodoquinol, isoniazid, metronidazole, <e1> nitrofurantoin </e1> , <e2> phenytoin </e2> , ribavirin, and vincristine.", "relation": "0", "e1": "nitrofurantoin", "e2": "phenytoin", "evs": ""}
{"sentence": "Concomitant use of <e1> L-phenylalanine </e1> and <e2> non-selective MAO inhibitors </e2> may cause hypertension.", "relation": "1", "e1": "L-phenylalanine", "e2": "non-selective MAO inhibitors", "evs": ""}
{"sentence": "<e1> Neuroleptic </e1> : <e2> pimozide </e2>", "relation": "0", "e1": "Neuroleptic", "e2": "pimozide", "evs": ""}
{"sentence": "Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: <e1> aminoglutethimide </e1> , p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, <e2> insulin </e2> , iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.", "relation": "0", "e1": "aminoglutethimide", "e2": "insulin", "evs": ""}
{"sentence": "Coadministration of Itraconazole with oral <e1> midazolam </e1> or <e2> triazolam </e2> has resulted in elevated plasma concentrations of the latter two drugs.", "relation": "0", "e1": "midazolam", "e2": "triazolam", "evs": ""}
{"sentence": "Some reports have shown that the concomitant administration of <e1> thiazides </e1> with <e2> vitamin D </e2> causes hypercalcemia.", "relation": "1", "e1": "thiazides", "e2": "vitamin D", "evs": ""}
{"sentence": "Sulindac: The concomitant administration of <e1> diflunisal </e1> and <e2> sulindac </e2> in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.", "relation": "1", "e1": "diflunisal", "e2": "sulindac", "evs": ""}
{"sentence": "Pre-treatment with the CYP3A4 inducer <e1> rifampicin </e1> decreased <e2> erlotinib </e2> AUC by about 2/3.", "relation": "1", "e1": "rifampicin", "e2": "erlotinib", "evs": ""}
{"sentence": "substrates, in vitro data suggest similar effects of <e1> grepafloxacin </e1> in CYP3A4 mediated metabolism and <e2> theophylline </e2> metabolism.", "relation": "0", "e1": "grepafloxacin", "e2": "theophylline", "evs": ""}
{"sentence": "Theophylline: As with some other <e1> quinolones </e1> , concurrent administration of ciprofloxacin with <e2> theophylline </e2> may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.", "relation": "1", "e1": "quinolones", "e2": "theophylline", "evs": ""}
{"sentence": "No significant interactions with digoxin, <e1> hydrochlorothiazide </e1> , hydralazine, sulfinpyrazone, oral <e2> contraceptives </e2> , tolbutamide, or warfarin have been observed.", "relation": "0", "e1": "hydrochlorothiazide", "e2": "contraceptives", "evs": ""}
